| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Advances in Brief |
Molecular Oncology Program [R. J. J., W. W., W. J. P.], Pathology Service [D. C.], and Biostatistics and Informatics Core [A. B. C.], H. Lee Moffitt Cancer Center and Research Institute, and Departments of Interdisciplinary Oncology [R. J. J., D. C., W. W., W. J. P.], Pediatrics [R. W. E.], and Pathology and Laboratory Medicine [R. W. E.], University of South Florida College of Medicine, Tampa, Florida 33612
p21Cip1 is a cyclin-dependent kinase inhibitor whose abundance increases in cells exposed to radiation or other DNA-damaging agents. Such increases activate a G1 checkpoint, which allows time for DNA repair before S phase entry. By inhibiting cell cycle progression, p21Cip1 potentially suppresses tumorigenesis, and in support, we show that p21Cip1 heterozygous and nullizygous mice develop more tumors than do wild-type mice when exposed to a single dose of
-irradiation. Importantly, we also show that p21Cip1 nullizygosity increases the incidence of metastatic tumors in irradiated mice. We suggest that p21Cip1 is haploinsufficient for tumor suppression and functions as an antimetastatic agent.
This article has been cited by other articles:
![]() |
M. Idogawa, Y. Sasaki, H. Suzuki, H. Mita, K. Imai, Y. Shinomura, and T. Tokino A Single Recombinant Adenovirus Expressing p53 and p21-targeting Artificial microRNAs Efficiently Induces Apoptosis in Human Cancer Cells Clin. Cancer Res., June 1, 2009; 15(11): 3725 - 3732. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Agarwal, C. M. Mateo, and S. J. Marx Rare Germline Mutations in Cyclin-Dependent Kinase Inhibitor Genes in Multiple Endocrine Neoplasia Type 1 and Related States J. Clin. Endocrinol. Metab., May 1, 2009; 94(5): 1826 - 1834. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. George, M. A. Sturmoski, R. May, S. M. Sureban, B. K. Dieckgraefe, S. Anant, and C. W. Houchen Loss of p21Waf1/Cip1/Sdi1 enhances intestinal stem cell survival following radiation injury Am J Physiol Gastrointest Liver Physiol, February 1, 2009; 296(2): G245 - G254. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Cen, A. Deguchi, and I. B. Weinstein Activation of Protein Kinase G Increases the Expression of p21CIP1, p27KIP1, and Histidine Triad Protein 1 through Sp1 Cancer Res., July 1, 2008; 68(13): 5355 - 5362. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Payne and C. J. Kemp Tumor suppressor genetics Carcinogenesis, December 1, 2005; 26(12): 2031 - 2045. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Devgan, C. Mammucari, S. E. Millar, C. Brisken, and G. P. Dotto p21WAF1/Cip1 is a negative transcriptional regulator of Wnt4 expression downstream of Notch1 activation Genes & Dev., June 15, 2005; 19(12): 1485 - 1495. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Hauser, L. Ma, D. Agrawal, E. Haura, W. D. Cress, and W. J. Pledger Efficient Down-Regulation of Cyclin A-Associated Activity and Expression in Suspended Primary Keratinocytes Requires p21Cip1 Mol. Cancer Res., February 1, 2004; 2(2): 96 - 104. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |